SPAC Guest Spotlight: Patrick Sturgeon
In this episode of The SPAC Podcast, Patrick Sturgeon, Managing Partner at Brookline Capital Markets, introduces his background and shares his experience navigating the SPAC landscape. With a career spanning investment banking and hands-on leadership as CFO of three SPACs that each completed acquisitions, Patrick has gained valuable insights from both the advisory and principal sides of the market.
Patrick highlights how Brookline Capital Markets, a boutique New York-based investment bank, focuses on underwriting and advisory in the SPAC space, while his CFO roles provided first-hand perspective on the lifecycle of deals and the lessons learned along the way.
Connect with the Guest:
Patrick Sturgeon – Managing Partner, Brookline Capital Markets
Website: https://brooklinecapmkts.com/
LinkedIn: https://www.linkedin.com/in/patrickasturgeon/
View all of their episodes here:
https://www.thespacpodcast.com/guests/patrick-a-sturgeon/
Connect with the Hosts & The SPAC Podcast:
Michael Blankenship LinkedIn: https://www.linkedin.com/in/mikeblankenship/
Joshua Wilson LinkedIn: https://www.linkedin.com/in/joshuabrucewilson/
YouTube Channel: https://www.youtube.com/@Thespacpodcast
#SPACs #CapitalMarkets #SPACPodcast #BrooklineCapitalMarkets #SPACTalk #PatrickSturgeon #DealMaking
Contact The SPAC Podcast:
https://www.thespacpodcast.com/contact/
Disclaimer:
Michael J. Blankenship is a licensed attorney and is a partner at Winston & Strawn LLP. Joshua Wilson is a licensed Florida real estate broker and holds FINRA Series 79 and Series 63 licensure. The content of this podcast is intended for informational and educational purposes only and should not be interpreted as legal, financial, or compliance advice. The views and opinions expressed by the hosts and guests are their own and do not necessarily reflect the official policies or positions of any regulatory agency, law firm, employer, or organization.
Listeners are encouraged to consult their own legal counsel, compliance professionals, or financial advisors to ensure adherence to applicable laws and regulations, including those enforced by the SEC, FINRA, and other regulatory bodies. This podcast does not constitute a solicitation, offer, or recommendation of any financial products, securities transactions, or legal services.
Let’s Connect on LinkedIn:
👉 Michael J. Blankenship - https://www.linkedin.com/in/mikeblankenship/
👉 Joshua Bruce Wilson - https://www.linkedin.com/in/joshuabrucewilson/
To Contact Us or Collaborate:
Michael: Mike Blankenship here with the SPAC Podcast. Today I’m joined by Patrick Sturgeon from Brookline Capital Markets. Patrick, welcome. Do you want to give a couple minutes about yourself?
Patrick Sturgeon: Sure. Well, first off, Michael, thank you and Josh for having us on the podcast today. I’m Patrick Sturgeon, a Managing Partner at Brookline Capital Markets. We’re a boutique investment bank headquartered in New York with SPACs being an area of focus. Not only are we underwriters and advisors in the SPAC space, I’ve also been the CFO of three SPACs that have all successfully completed acquisitions, each in different parts of the SPAC market cycle. That gave me a lot of good learning lessons and stories from being on the principal side.
Patrick A. Sturgeon
Managing Partner
Patrick Sturgeon is a Managing Partner at Brookline Capital Markets, a division of Arcadia Securities, LLC, a Healthcare focused investment bank which provides capital raising, M&A, and strategic advisory services. He has completed a diverse series of transactions to include Initial Public Offerings, PIPEs, Follow-Ons, Private Placements from Series A through Private-to-Public Crossovers, Asset Back Lending, Buy & Sell-Side Merger Advisory, Secondary Trading and Strategic Advisory Services. He is asked to speak at events on topics to include the equity capital markets, the healthcare industry and transaction execution.
He has been the Chief Financial Officer of three biotech focused SPACs that have successfully closed acquisitions – Alpha Healthcare Acquisition Corp. (Humacyte (NASDAQ: HUMA) – first company to have RMAT designation), Alpha Healthcare Acquisition Corp. III (Carmell Corp. – Platelet-rich plasma (PRP) therapeutic focused on wound healing) and Brookline Capital Acquisition Corp I (Apexigen – Oncology focused). He continues to serve as Vice Chairman to the public company Longevity Health Holdings (NASDAQ: XAGE).
As a Founding Partner of Covenant Venture Capital, Mr. Sturgeon has led investments in prominent companies like Anduril, Anthropic, EpiBone, Dataminr, SpaceX and others, demonstrating his strategic investment acumen across high growth sectors such as artificial intelligence, biotech, data analytics and defense. He led the process to have Covenant confirmed as a Qualified Venture Fund for NJEDA which allows them to receive matching inve…
Read More